发明授权
![Imidazo[4,5-c]pyridine and pyrrolo[2,3-c]pyridine derivatives as SSAO inhibitors](/docs/US/2021-04-06/US10968223B2/abs.jpg.600x600.jpg)
- 专利标题： Imidazo[4,5-c]pyridine and pyrrolo[2,3-c]pyridine derivatives as SSAO inhibitors
-
申请号： US16933417申请日： 2020-07-20
-
公开(公告)号： US10968223B2公开(公告)日： 2021-04-06
- 发明人: Max Espensen , Lee Patient , David Evans , Iain Simpson , Edward Savory
- 申请人： PROXIMAGEN, LLC
- 申请人地址： US MN Plymouth
- 专利权人： PROXIMAGEN, LLC
- 当前专利权人： PROXIMAGEN, LLC
- 当前专利权人地址： US MN Plymouth
- 代理机构： Ballard Spahr LLP
- 优先权： GB1304526 20130313
- 主分类号： C07D471/04
- IPC分类号： C07D471/04 ; A61K31/40 ; A61K31/4745 ; A61K31/495 ; A61K31/501 ; A61K31/506 ; C07C53/18
![Imidazo[4,5-c]pyridine and pyrrolo[2,3-c]pyridine derivatives as SSAO inhibitors](/abs-image/US/2021/04/06/US10968223B2/abs.jpg.150x150.jpg)
摘要：
A process for the preparation of a compound of formula (Ia) or a pharmaceutically acceptable salt, or N-oxide thereof that includes reacting a compound of formula (IIIa) or (Va) with a compound of formula (IX) to form the compound of formula (Ia)